“The role of miRNA200a as biomarker to detect breast and ovarian cancers in Iraqi women”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 463–467, Oct. 2022, doi: 10.47750/pnr.2022.13.04.059.